Treace Medical Concepts annual operating margin
2019
2020
2021
2022
2023
2024
2025
Treace Medical Concepts's operating margin was −25.46% for fiscal 2025.
View full Treace Medical Concepts company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −25.46% | +1.14 pp |
| 2024 | 2024-12-31 | −26.60% | +0.88 pp |
| 2023 | 2023-12-31 | −27.48% | −2.92 pp |
| 2022 | 2022-12-31 | −24.57% | −7.08 pp |
| 2021 | 2021-12-31 | −17.49% | −18.98 pp |
| 2020 | 2020-12-31 | 1.49% | +10.46 pp |
| 2019 | 2019-12-31 | −8.97% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −32.96% | +2.86 pp |
| Q1 2026 | 2026-03-31 | −36.37% | −6.73 pp |
| Q4 2025 | 2025-12-31 | −9.47% | −9.18 pp |
| Q3 2025 | 2025-09-30 | −31.22% | +2.35 pp |
| Q2 2025 | 2025-06-30 | −35.82% | +12.28 pp |
| Q1 2025 | 2025-03-31 | −29.64% | +7.47 pp |
| Q4 2024 | 2024-12-31 | −0.30% | +10.60 pp |
| Q3 2024 | 2024-09-30 | −33.57% | +10.15 pp |
| Q2 2024 | 2024-06-30 | −48.10% | −16.99 pp |
| Q1 2024 | 2024-03-31 | −37.11% | −4.47 pp |
| Q4 2023 | 2023-12-31 | −10.90% | −3.87 pp |
| Q3 2023 | 2023-09-30 | −43.72% | −9.48 pp |
| Q2 2023 | 2023-06-30 | −31.11% | +8.71 pp |
| Q1 2023 | 2023-03-31 | −32.65% | −4.78 pp |
| Q4 2022 | 2022-12-31 | −7.03% | +9.71 pp |
| Q3 2022 | 2022-09-30 | −34.24% | −8.98 pp |
| Q2 2022 | 2022-06-30 | −39.82% | −20.21 pp |
| Q1 2022 | 2022-03-31 | −27.87% | −20.38 pp |
| Q4 2021 | 2021-12-31 | −16.74% | −31.82 pp |
| Q3 2021 | 2021-09-30 | −25.26% | −24.81 pp |
| Q2 2021 | 2021-06-30 | −19.61% | +0.00 pp |
| Q1 2021 | 2021-03-31 | −7.49% | +3.16 pp |
| Q4 2020 | 2020-12-31 | 15.08% | — |
| Q3 2020 | 2020-09-30 | −0.44% | — |
| Q2 2020 | 2020-06-30 | −19.61% | — |
| Q1 2020 | 2020-03-31 | −10.65% | — |
Over the last five reported fiscal years, Treace Medical Concepts's operating margin decreased from 1.49% to −25.46%, a change of −26.95 percentage points. The latest reported quarter, Q2 2026, shows −32.96%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Treace Medical Concepts filings at SEC.gov ↗